Sight Sciences Secures $34M Patent Win Against Alcon, Gains 10% Hydrus Royalty
SGHT sits 95% above its 52-week low of $2.03.
Summary
A U.S. District Court issued an order on post-trial motions in Sight Sciences' patent infringement case against Alcon, upholding the jury's verdict. The court awarded Sight Sciences $34 million in monetary damages for past infringement, along with supplemental damages and interest. Crucially, the order also grants an ongoing royalty of 10% of Hydrus revenue through November 10, 2028. This is a highly material financial victory for Sight Sciences, with the $34 million award representing a significant portion of its market capitalization. The additional ongoing royalty stream provides a substantial boost to future revenue and profitability, significantly improving the company's financial outlook and valuation.
At the time of this announcement, SGHT was trading at $3.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $209.5M. The 52-week trading range was $2.03 to $9.24. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.